In contrast, it has been demonstrated that Fgf15/FGF19 is overexpressed in patients with hepatocellular carcinoma, correlates with tumor progression/poor prognosis and exerts tumor-promoting effects25, 26. Here, FGF19 is linked to hepatocellular carcinoma.